Effectiveness of Motivational Interview in Patients With Dyslipidemia

Conditions

Patients With Dyslipidemia

Keywords

dyslipidemia, motivational interview, prevention

Brief summary

Evaluate the effectiveness of motivational interviewing to improve lipid control and cardiovascular risk in patients with dyslipidemia.

Julia Bóveda-Fontán, Nieves Barragán-Brun, Manuel Campíñez-Navarro, Luis Ángel Pérula de Torres, Josep M. Bosch-Fontcuberta et al. (12 authors)

BMC Family Practice2015-10-2426 citations

10.1186/s12875-015-0370-2

Is the Scale for Measuring Motivational Interviewing Skills a valid and reliable instrument for measuring the primary care professionals motivational skills?: EVEM study protocol.

Pérula LÁ, Campiñez M, Bosch JM, Barragán Brun N, Arboniés JC, Bóveda Fontán J, Martín Alvarez R, Prados JA, Martín-Rioboó E, Massons J, Criado M, Fernández JÁ, Parras JM, Ruiz-Moral R, Novo JM, collaborative Group Dislip-EM.

2012-11-2210 citations

10.1186/1471-2296-13-112

Effectiveness of Motivational Interviewing in improving lipid level in patients with dyslipidemia assisted by general practitioners: Dislip-EM study protocol.

Pérula LA, Bosch JM, Bóveda J, Campiñez M, Barragán N, Arboniés JC, Prados JA, Martín E, Martín R, Massons J, Criado M, Ruiz R, Fernández JA, Buitrago F, Olaya I, Pérez M, Ruiz J.

2011-11-057 citations

10.1186/1471-2296-12-125

Interventions

BEHAVIORALMotivational interview

Motivational interview

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* People diagnosed with dyslipidemia * To sign informed consent.

Exclusion criteria

* Secondary hypercholesterolemia. * Familial hypercholesterolemia. * Deficiency syndromes family high density lipoprotein. * Subjects with a history of cardiac or cerebrovascular events. * Other chronic health problems such as diabetes or severe COPD. * Subjects with current diagnosis of cancer. * Patients with hepatic or renal disorders . * Subjects heavy drinkers. * Patients with long standing sick leave (more than 6 months). * Pregnant or breastfeeding.

Design outcomes

Primary

Measure	Time frame
lipid levels	12 months

Secondary

Measure	Time frame
cardiovascular risk	12 months

Countries

Spain

Outcome results

None listed